Central Tobacco Research Institute, India solanesol patent

Central Tobacco Research Institute, India solanesol patent

Now, the tobacco will be the Central Tobacco Research Institute for the manufacture of the treatment of cancer and cardiac drugs, solanesol patent. Solanesol is extracted from tobacco material.

Extracted from green tobacco leaves, white powder eggplant alcohol, the myocardium can be incomplete, muscular dystrophy, anemia, cancer, diabetes, hypertension, asthma and liver damage is curative. “Many pharmaceutical companies have been in touch with us, carried out using solanesol as anti-cancer and anti-diabetic drugs, medical tests, V Krishna Murthy, director of the Central Tobacco Research Institute.

Solanesol is very rich in the coenzyme 10 – This is a substance of high pharmaceutical value. Solanesol as a drug has a bright future, Central Tobacco Research Institute will soon be in the right to allocate the production of drugs on the market, “Murthy said. In October 2007, the Central Tobacco Research Institute solanesol patent from the Patent Office.

Solanesol extracted from tobacco, is a joint project between the Central Tobacco Research Institute and the Central Drug Research Institute. The CTRI use chewing tobacco varieties grown in Tamil Nadu Abirmani and in the black soils of Andhra La Banggong Turku HDBRG tobacco.